naturalnews.com printable article

Originally published April 11 2004

Pharmaceutical companies declare war on the human body with smart bombs

by Mike Adams, the Health Ranger, NaturalNews Editor

What's interesting about Genentech's announcement of its overhyped drug for colon cancer isn't the news itself: it's the terminology used by the industry to describe this class of drugs. They're called "smart-bomb drugs." That's right: smart bombs. Like the kind the United States drops on residential buildings in Iraq.

The use of this terminology reveals the underlying philosophy of Western medicine: the body is a battleground. Drugs are weapons. Diseases are the enemy. To cure the patient, you must destroy the disease using whatever weapons are necessary!

That's the language of Western medicine, and it's completely wrong. The body isn't a battleground, it is a self-healing system. The disease isn't an enemy, it is the inevitable expression of a body that's out of balance. You don't help patients by using "weapons of mass destruction," you help patients by bringing them back into balance (good nutrition, physical exercise, avoidance of all metabolic disruptors, and supplementation with superfoods and medicinal herbs, if needed) and then allowing their own bodies to conduct the healing process.

But Western doctors just want to go in and wipe things out. They slice out tumors with sharp knives. They burn tumors with deadly radiation. They poison the entire patient with toxic chemotherapy. That's not medicine, folks. That's medical insanity.

The true causes of healing simply aren't understood by Western medicine, and certainly not by pharmaceutical companies. The human body already knows how to heal itself. All you have to do is stop poisoning your body (with junk foods, soft drinks and prescription drugs) and start treating yourself right. It's really no more complicated than good nutrition, physical exercise, and stress reduction. Good health is well within your reach.



NEW YORK - The U.S. Food and Drug Administration has approved Genentech's colon cancer drug Avastin, one of the most anticipated medicines in all of oncology, a month before a regulatory decision was due. That's great news for San Francisco-based Genentech (nyse: DNA - news - people), and for Basel, Switzerland-based Roche, which owns a majority stake in the biotech standard-bearer. For an even bigger bird's-eye view of drugs in development, check out "New Drugs To Watch," our wide-ranging watch list of new medicines. Apply For A Mortgage Today's Mortgage Rates Home Equity Mortgage Calculator Free Credit Report FHA & VA Mortgage Loans Buyers Calculator How Much Can You Borrow?


All content posted on this site is commentary or opinion and is protected under Free Speech. Truth Publishing LLC takes sole responsibility for all content. Truth Publishing sells no hard products and earns no money from the recommendation of products. NaturalNews.com is presented for educational and commentary purposes only and should not be construed as professional advice from any licensed practitioner. Truth Publishing assumes no responsibility for the use or misuse of this material. For the full terms of usage of this material, visit www.NaturalNews.com/terms.shtml